Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,461 to 1,480 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA. | Nat Commun | 2020 | 33077732 | PubTator, text mining | PubMed |
| Post-Transcriptional Expression Control in Platelet Biogenesis and Function. | Int J Mol Sci | 2020 | 33076269 | PubTator, text mining | PubMed |
| Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms. | PLoS One | 2020 | 33075099 | PubTator, text mining | PubMed |
| The functions and clinical significance of circRNAs in hematological malignancies. | J Hematol Oncol | 2020 | 33069241 | PubTator, text mining | PubMed |
| [Clinical Prognostic Factors Analysis of Initially Treated AML Children with t(8;21)/RUNX1-RUNX1T1]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2020 | 33067946 | PubTator, text mining | PubMed |
| Benefit of intermediate-dose cytarabine containing induction in molecular subgroups of acute myeloid leukemia. | Haematologica | 2020 | 33054134 | PubTator, text mining | PubMed |
| Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia. | Haematologica | 2020 | 33054062 | PubTator, text mining | PubMed |
| Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets. | Cancers (Basel) | 2020 | 33050637 | PubTator, text mining | PubMed |
| Circulating microRNAs in Breast Milk and Their Potential Impact on the Infant. | Nutrients | 2020 | 33049923 | PubTator, text mining | PubMed |
| lncRNA involved in triptonide-induced cytotoxicity in mouse germ cells. | Reprod Toxicol | 2020 | 33045310 | PubTator, text mining | PubMed |
| Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible. | Front Oncol | 2020 | 33042819 | PubTator, text mining | PubMed |
| Advancing leukemia diagnostics: Role of Next Generation Sequencing (NGS) in acute myeloid leukemia. | Hematol Rep | 2020 | 33042506 | PubTator, text mining | PubMed |
| Photosynthesis Performance and Antioxidative Enzymes Response of Melia azedarach and Ligustrum lucidum Plants Under Pb-Zn Mine Tailing Conditions. | Front Plant Sci | 2020 | 33042188 | PubTator, text mining | PubMed |
| DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets. | Cancers (Basel) | 2020 | 33036275 | PubTator, text mining | PubMed |
| TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment. | Cell Rep | 2020 | 33027668 | PubTator, text mining | PubMed |
| Short Dysfunctional Telomere Is Highly Predictive of Dismal Outcome in MDS but Not in AML Patients. | Int J Hematol Oncol Stem Cell Res | 2020 | 33024526 | PubTator, text mining | PubMed |
| Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials. | Front Genet | 2020 | 33024443 | PubTator, text mining | PubMed |
| PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance. | Front Cell Dev Biol | 2020 | 33015058 | PubTator, text mining | PubMed |
| Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation. | Front Immunol | 2020 | 33013836 | PubTator, text mining | PubMed |
| Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells. | Biomedicines | 2020 | 32998330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=74